+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Heparin Market By Type, By Application, By Route of Administration, By End Use, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

  • ID: 5387571
  • Report
  • June 2021
  • Region: Europe
  • 94 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • LEO Pharma A/S
  • Pfizer, Inc.
  • Sanofi S.A.
  • Viatris, Inc.
  • MORE
The Europe Heparin Market is expected to witness market growth of 6.2% CAGR during the forecast period (2021-2027).

The demand for anticoagulants is very high and it is anticipated to boost the overall heparin market. Moreover, the increased healthcare expenditures and growing awareness levels among the patient are the major factors expected to drive the global heparin market over the forecast period.

The growing burden of chronic diseases is the main factor for the growth of the heparin market. As per the World Health Organization, chronic diseases are a massive global challenge for decades and account for almost 60% of all deaths across the globe. The worldwide burden of chronic diseases may reach 57% by the end of 2020.

In the past few decades, it has been reported that there are increasing incidences of venous thrombosis and cardiovascular diseases across the globe including heart attacks and strokes. It is the major factor that is driving the growth of the global heparin market. Moreover, as heparin is used in various surgeries including orthopaedic and heart surgeries, and rise in the number of patients undergoing such surgeries is expected to further boost the growth of the heparin market. Cardiovascular diseases have a direct impact on the heparin market growth.

The demand for heparin is high in European counties. It is due to the increasing adoption of technologically advanced products in the healthcare sector in this region. The increasing number of patients who are suffering from cardiovascular diseases is very high among the region’s population. This will open new growth avenues in the heparin market in this region. The medical infrastructure is very advanced in the UK. The whole population’s medical expenses are covered by the National Health System. It is financed through general taxation and independently-run by the Department of Health. The major cause of death in the UK is due to coronary heart disease (CHD). The use of heparin in the treatment of CHD is increasing exponentially. Thus, it is expected that the demand for heparin will increase in the forecast period and positively contribute to the growth of the market. Although there is a decline in death rates due to cardiovascular disease (CVD) in the UK, rates are still comparatively high than other Western European countries.

The Germany market dominated the Europe Venous Thromboembolism Market by Country 2020, thereby, achieving a market value of $100.2 million by 2027. The UK market is exhibiting a CAGR of 6.7% during (2021 - 2027). Additionally, The France market is poised to grow at a CAGR of 8.2% during (2021 - 2027).

Based on Type, the market is segmented into Low Molecular Weight Heparin, Unfractionated Heparin and Ultra-low Molecular Weight Heparin. Based on Application, the market is segmented into Atrial Fibrillation, Coronary Artery Disease, Venous Thromboembolism, Renal Impairment and Other Applications. Based on Route of Administration, the market is segmented into Subcutaneous and Intravenous. Based on End Use, the market is segmented into Outpatient and Inpatient. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Pfizer, Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Dr. Reddy’s Laboratories Ltd., LEO Pharma A/S, and Viatris, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type
  • Low Molecular Weight Heparin
  • Unfractionated Heparin
  • Ultra-low Molecular Weight Heparin
By Application
  • Atrial Fibrillation
  • Coronary Artery Disease
  • Venous Thromboembolism
  • Renal Impairment
  • Other Applications
By Route of Administration
  • Subcutaneous
  • Intravenous
By End Use
  • Outpatient
  • Inpatient
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Baxter International, Inc.
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Pfizer, Inc.
  • Sanofi S.A.
  • Teva Pharmaceuticals Industries Ltd.
  • Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • LEO Pharma A/S
  • Viatris, Inc.
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • LEO Pharma A/S
  • Pfizer, Inc.
  • Sanofi S.A.
  • Viatris, Inc.
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Heparin Market, by Type
1.4.2 Europe Heparin Market, by Application
1.4.3 Europe Heparin Market, by Route of Administration
1.4.4 Europe Heparin Market, by End Use
1.4.5 Europe Heparin Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Heparin Market by Type
3.1 Europe Low Molecular Weight Heparin Market by Country
3.2 Europe Unfractionated Heparin Market by Country
3.3 Europe Ultra-low Molecular Weight Heparin Market by Country

Chapter 4. Europe Heparin Market by Application
4.1 Europe Atrial Fibrillation Market by Country
4.2 Europe Coronary Artery Disease Market by Country
4.3 Europe Venous Thromboembolism Market by Country
4.4 Europe Renal Impairment Market by Country
4.5 Europe Other Applications Market by Country

Chapter 5. Europe Heparin Market by Route of Administration
5.1 Europe Subcutaneous Market by Region
5.2 Europe Intravenous Market by Region

Chapter 6. Europe Heparin Market by End Use
6.1 Europe Outpatient Market by Country
6.2 Europe Inpatient Market by Country

Chapter 7. Europe Heparin Market by Region
7.1 Germany Heparin Market
7.1.1 Germany Heparin Market by Type
7.1.2 Germany Heparin Market by Application
7.1.3 Germany Heparin Market by Route of Administration
7.1.4 Germany Heparin Market by End Use
7.2 UK Heparin Market
7.2.1 UK Heparin Market by Type
7.2.2 UK Heparin Market by Application
7.2.3 UK Heparin Market by Route of Administration
7.2.4 UK Heparin Market by End Use
7.3 France Heparin Market
7.3.1 France Heparin Market by Type
7.3.2 France Heparin Market by Application
7.3.3 France Heparin Market by Route of Administration
7.3.4 France Heparin Market by End Use
7.4 Russia Heparin Market
7.4.1 Russia Heparin Market by Type
7.4.2 Russia Heparin Market by Application
7.4.3 Russia Heparin Market by Route of Administration
7.4.4 Russia Heparin Market by End Use
7.5 Spain Heparin Market
7.5.1 Spain Heparin Market by Type
7.5.2 Spain Heparin Market by Application
7.5.3 Spain Heparin Market by Route of Administration
7.5.4 Spain Heparin Market by End Use
7.6 Italy Heparin Market
7.6.1 Italy Heparin Market by Type
7.6.2 Italy Heparin Market by Application
7.6.3 Italy Heparin Market by Route of Administration
7.6.4 Italy Heparin Market by End Use
7.7 Rest of Europe Heparin Market
7.7.1 Rest of Europe Heparin Market by Type
7.7.2 Rest of Europe Heparin Market by Application
7.7.3 Rest of Europe Heparin Market by Route of Administration
7.7.4 Rest of Europe Heparin Market by End Use

Chapter 8. Company Profiles
8.1 Baxter International, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Fresenius SE & Co. KGaA
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.1 Recent strategies and developments:
8.3.1.1 Partnerships, Collaborations, and Agreements:
8.3.1.2 Acquisition and Mergers:
8.3.1.3 Product Launches and Product Expansions:
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Sanofi S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.7 Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
8.7.1 Company Overview
8.8 Dr. Reddy’s Laboratories Ltd.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 LEO Pharma A/S
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.10. Viatris, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
  • Baxter International, Inc.
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Pfizer, Inc.
  • Sanofi S.A.
  • Teva Pharmaceuticals Industries Ltd.
  • Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • LEO Pharma A/S
  • Viatris, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll